Previous 10 | Next 10 |
Second-quarter revenues increased 3% on a reported basis and 4% on a constant currency basis, ahead of the company’s previously issued guidance 1 Second-quarter U.S. GAAP earnings (loss) per share (EPS) (including discontinued operations) of ($0.28); adjusted EPS (including discont...
2023-07-26 12:31:50 ET Baxter ( NYSE: BAX ) is scheduled to announce Q2 earnings results on Thursday, July 27th, before market open. The consensus EPS Estimate is $0.61 (-29.9% Y/Y) and the consensus Revenue Estimate is $3.79B (+1.1% Y/Y). Over the last 2 years, BAX ...
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that Vantive will be the name of the company’s proposed spinoff of its Renal Care and Acute Therapies businesses. Vantive is expected to launch as an independent, publicly traded company by July 2024 or earlier,...
2023-07-24 13:58:17 ET Baxter International ( NYSE: BAX ) has announced the launch of PERCLOT Absorbable Hemostatic Powder in the U.S. PERCLOT is a passive, absorbable hemostatic powder that is ready to use and designed for patients with intact coagulation to address mild ...
Marks first passive hemostat for Baxter in the U.S. market, broadening portfolio offering to include a full range of active and passive hemostatic products Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of PERCLOT A...
2023-07-20 12:30:04 ET Omnicell ( NASDAQ: OMCL ) traded lower on Thursday after Wells Fargo downgraded the pharmacy service provider to Underweight from Overweight, citing risks to the company’s year-to-date rally. The analyst Stan Berenshteyn argues that Omnicell ( OMC...
2023-07-14 00:21:43 ET Summary Inflation has dropped to the mid to low 3% levels as predicted, with the 10-year yield and USD also falling. Despite this, expectations of the Federal Reserve skipping a hike at the July meeting have not changed, though this may alter in the future. ...
2023-07-13 05:37:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
2023-07-13 01:00:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
NEW YORK, NY / ACCESSWIRE / July 12, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Baxter International Inc. ("Baxter" or "the Company") (NYSE:BAX). Investors who purchased Baxter securities are encouraged to obtain additional informat...
News, Short Squeeze, Breakout and More Instantly...
Baxter International Inc. Company Name:
BAX Stock Symbol:
NYSE Market:
Baxter International Inc. Website:
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2024 financial results on Tuesday, August 6, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direc...
Provides updates on Baxter’s 2030 Corporate Responsibility Commitment and Goals and reinforces the company’s commitment to transparent reporting Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2023 Corporate Responsibility Report . Th...
2024-06-28 08:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...